Mariner’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$53M Buy
119,123
+2,562
+2% +$1.14M 0.08% 226
2025
Q1
$56.5M Sell
116,561
-5,856
-5% -$2.84M 0.09% 194
2024
Q4
$49.3M Sell
122,417
-1,077
-0.9% -$434K 0.08% 213
2024
Q3
$57.4M Buy
123,494
+2,082
+2% +$968K 0.1% 188
2024
Q2
$56.9M Buy
121,412
+5,951
+5% +$2.79M 0.11% 170
2024
Q1
$48.3M Buy
115,461
+6,518
+6% +$2.72M 0.1% 197
2023
Q4
$44.3M Buy
108,943
+12,331
+13% +$5.02M 0.11% 189
2023
Q3
$33.6M Buy
96,612
+3,382
+4% +$1.18M 0.09% 205
2023
Q2
$32.8M Buy
93,230
+1,828
+2% +$643K 0.09% 211
2023
Q1
$28.8M Buy
91,402
+59,637
+188% +$18.8M 0.08% 223
2022
Q4
$9.2M Buy
31,765
+13,022
+69% +$3.77M 0.03% 429
2022
Q3
$5.43M Buy
18,743
+7,262
+63% +$2.1M 0.02% 488
2022
Q2
$3.24M Buy
11,481
+460
+4% +$130K 0.01% 589
2022
Q1
$2.88M Buy
+11,021
New +$2.88M 0.01% 630
2019
Q3
Sell
-1,302
Closed -$239K 1048
2019
Q2
$239K Buy
1,302
+39
+3% +$7.16K ﹤0.01% 975
2019
Q1
$232K Buy
+1,263
New +$232K ﹤0.01% 915